Aging adults with a history of cannabis use exhibit greater cognitive performance than those with no or little history of ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss the regulatory and legal landscape around ...

President Donald Trump is expected to sign an executive order rescheduling marijuana as a Schedule III drug, placing it on the same level as Tylenol with codeine, testosterone or anabolic steroids.

Welcome back to the buzz, our monthly cannabis news and policy update. Your at-a-glance source for regulatory developments, agency announcements, and trends impacting the cannabis industry. In this ...

Cannabis has been linked to some significant medical benefits, but recent research calls those into question. A major new analysis published in JAMA examined more than 2,500 scientific papers from the ...

Michigan's cannabis market is one of the largest markets in the country by volume. A 24% tax on marijuana threatens to ...

It is the third dispensary to open in Central Kentucky this month.

WASHINGTON — Cannabis policy in the United States is going through big changes. President Donald Trump is expected imminently to sign an executive order expediting the rescheduling of marijuana as a ...

Note: This article was originally published in May 2024, when the Drug Enforcement Administration formally recommended rescheduling cannabis. It has been updated to an executive order from the Trump ...